CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

A study on incidence, risk factors and microbiological profile of ventilator associated pneumonia in a tertiary care Referral centre : Kerala, South India

Author: 
Rohey Jan, Waseem Raja, Nita George, Mohan Mathew, George Jacob and Monika, D.
Subject Area: 
Health Sciences
Abstract: 

Background: Ventilator-associated pneumonia (VAP) is the most common nosocomial infection diagnosed in the intensive care unit (ICU) and in spite of advances in diagnostic techniques and management it remains a common cause of hospital morbidity and mortality. Aims/objective: The aim of the study was to determine the incidence, the bacterial pathogens causing VAP in our setup, along with the susceptibility pattern for antibiotics and detect the multi-drug resistant pathogens among them. Materials and Methods: This prospective study was conducted in department of Critical Care Medicine, Lakeshore hospital & research centre over a period of 2 years from November 2014 to October 2016, enrolling patients undergoing mechanical ventilation for >48h in MICU’s. Exclusion criteria- age <12 years, patients with COPD, Tuberculosis, ARDS, Bronchial asthma on admission & patients with Pneumonia prior to or within 48 hours of mechanical ventilation are excluded from the study .Endotracheal aspirates were collected from patients with suspected VAP and semi-quantitative cultures were performed on all samples. VAP was diagnosed using Clinical Pulmonary Infection Score (CPIS). Results: Out of 100 cases studied, 19 (19%) patients were diagnosed to have VAP, out of which 42.11% had early-onset (< 96 hours of mechanical ventilation) VAP and 57.89% had late-onset (>96 hours of mechanical ventilation) VAP. Ventilator associated pneumonia was more preponderant in males (63.15), the commonest age group being >60 years followed by age group 41 to 50 years (26.3%). Reintubation of more than one times, infection at other sites and prolonged ventilation are the risk factors for VAP. Acinetobacter species followed by Pseudomonas aeruginosa were the most commonly isolated pathogens in both types of VAP. Antibiotic sensitivity pattern revealed most of the pathogens to be multi-drug resistant. There is significant difference in VAP and Non-VAP groups in terms of outcome variables like death, and discharge from the hospital. Motality rate in our study was 26%, which was significantly higher in late onset VAP due to MDR pathogens. VAP prolongs the duration of mechanical ventilation, length of intensive care and the duration of hospital stay compared to the Non VAP cases. Conclusions: This study provides a baseline data of current scenario of VAP in our set up, which can be utilized to formulate infection control strategies. The present study also shows that VAP is increasingly associated with MDR pathogens which lead to increased mortality, morbidity and indirectly the health care costs.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran